Besides, it is speculated that Epac proteins may also involve in the AD progression because Epac mediates secretion of the non-amyloidogenic protective form of APP, sAPPα, induced by 5-HT4 receptor activation in vitro.91, 92. Here, RAPGEF4 is linked to Alzheimer disease.